247 related articles for article (PubMed ID: 20519569)
1. A Drosophila melanogaster model of classic galactosemia.
Kushner RF; Ryan EL; Sefton JM; Sanders RD; Lucioni PJ; Moberg KH; Fridovich-Keil JL
Dis Model Mech; 2010; 3(9-10):618-27. PubMed ID: 20519569
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation.
Daenzer JM; Jumbo-Lucioni PP; Hopson ML; Garza KR; Ryan EL; Fridovich-Keil JL
Dis Model Mech; 2016 Nov; 9(11):1375-1382. PubMed ID: 27562100
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia.
Jumbo-Lucioni PP; Hopson ML; Hang D; Liang Y; Jones DP; Fridovich-Keil JL
Dis Model Mech; 2013 Jan; 6(1):84-94. PubMed ID: 22773758
[TBL] [Abstract][Full Text] [Related]
4. Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia.
Ryan EL; DuBoff B; Feany MB; Fridovich-Keil JL
Dis Model Mech; 2012 Nov; 5(6):796-803. PubMed ID: 22736462
[TBL] [Abstract][Full Text] [Related]
5. A galactose-1-phosphate uridylyltransferase-null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue-specific and longitudinal differences in galactose metabolism.
Rasmussen SA; Daenzer JMI; MacWilliams JA; Head ST; Williams MB; Geurts AM; Schroeder JP; Weinshenker D; Fridovich-Keil JL
J Inherit Metab Dis; 2020 May; 43(3):518-528. PubMed ID: 31845342
[TBL] [Abstract][Full Text] [Related]
6. Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.
Balakrishnan B; An D; Nguyen V; DeAntonis C; Martini PGV; Lai K
Mol Ther; 2020 Jan; 28(1):304-312. PubMed ID: 31604675
[TBL] [Abstract][Full Text] [Related]
7. Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia.
Jumbo-Lucioni PP; Ryan EL; Hopson ML; Bishop HM; Weitner T; Tovmasyan A; Spasojevic I; Batinic-Haberle I; Liang Y; Jones DP; Fridovich-Keil JL
Antioxid Redox Signal; 2014 May; 20(15):2361-71. PubMed ID: 23758052
[TBL] [Abstract][Full Text] [Related]
8. Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model.
Slepak TI; Tang M; Slepak VZ; Lai K
Mol Genet Metab; 2007; 92(1-2):78-87. PubMed ID: 17643331
[TBL] [Abstract][Full Text] [Related]
9. Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase.
Riehman K; Crews C; Fridovich-Keil JL
J Biol Chem; 2001 Apr; 276(14):10634-40. PubMed ID: 11152465
[TBL] [Abstract][Full Text] [Related]
10. Drosophila melanogaster Models of Galactosemia.
Daenzer JM; Fridovich-Keil JL
Curr Top Dev Biol; 2017; 121():377-395. PubMed ID: 28057307
[TBL] [Abstract][Full Text] [Related]
11. Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.
Tang M; Siddiqi A; Witt B; Yuzyuk T; Johnson B; Fraser N; Chen W; Rascon R; Yin X; Goli H; Bodamer OA; Lai K
Eur J Hum Genet; 2014 Oct; 22(10):1172-9. PubMed ID: 24549051
[TBL] [Abstract][Full Text] [Related]
12. The structural and molecular biology of type I galactosemia: Enzymology of galactose 1-phosphate uridylyltransferase.
McCorvie TJ; Timson DJ
IUBMB Life; 2011 Sep; 63(9):694-700. PubMed ID: 21793161
[TBL] [Abstract][Full Text] [Related]
13. Galactosemia: when is it a newborn screening emergency?
Berry GT
Mol Genet Metab; 2012 May; 106(1):7-11. PubMed ID: 22483615
[TBL] [Abstract][Full Text] [Related]
14. Galactose 1-phosphate accumulates to high levels in galactose-treated cells due to low GALT activity and absence of product inhibition of GALK.
Oh SL; Cheng LY; J Zhou JF; Henke W; Hagen T
J Inherit Metab Dis; 2020 May; 43(3):529-539. PubMed ID: 31774565
[TBL] [Abstract][Full Text] [Related]
15. A frequent splicing mutation and novel missense mutations color the updated mutational spectrum of classic galactosemia in Portugal.
Coelho AI; Ramos R; Gaspar A; Costa C; Oliveira A; Diogo L; Garcia P; Paiva S; Martins E; Teles EL; Rodrigues E; Cardoso MT; Ferreira E; Sequeira S; Leite M; Silva MJ; de Almeida IT; Vicente JB; Rivera I
J Inherit Metab Dis; 2014 Jan; 37(1):43-52. PubMed ID: 23749220
[TBL] [Abstract][Full Text] [Related]
16. Neonatal GALT gene replacement offers metabolic and phenotypic correction through early adulthood in a rat model of classic galactosemia.
Daenzer JMI; Rasmussen SA; Patel S; McKenna J; Fridovich-Keil JL
J Inherit Metab Dis; 2022 Mar; 45(2):203-214. PubMed ID: 34964137
[TBL] [Abstract][Full Text] [Related]
17. Effect of genotype on galactose-1-phosphate in classic galactosemia patients.
Yuzyuk T; Balakrishnan B; Schwarz EL; De Biase I; Hobert J; Longo N; Mao R; Lai K; Pasquali M
Mol Genet Metab; 2018 Nov; 125(3):258-265. PubMed ID: 30172461
[TBL] [Abstract][Full Text] [Related]
18. Impaired fertility and motor function in a zebrafish model for classic galactosemia.
Vanoevelen JM; van Erven B; Bierau J; Huang X; Berry GT; Vos R; Coelho AI; Rubio-Gozalbo ME
J Inherit Metab Dis; 2018 Jan; 41(1):117-127. PubMed ID: 28913702
[TBL] [Abstract][Full Text] [Related]
19. UDP-galactose 4' epimerase (GALE) is essential for development of Drosophila melanogaster.
Sanders RD; Sefton JM; Moberg KH; Fridovich-Keil JL
Dis Model Mech; 2010; 3(9-10):628-38. PubMed ID: 20519568
[TBL] [Abstract][Full Text] [Related]
20. Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.
Ryan EL; Lynch ME; Taddeo E; Gleason TJ; Epstein MP; Fridovich-Keil JL
J Inherit Metab Dis; 2013 Nov; 36(6):1049-61. PubMed ID: 23319291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
